Showing results (1891-1900 of 1,915) with videos related to
Sort By:
Pageof 192
The Journal of Infectious Diseases|October 13, 2011
Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trialSusan H Eshleman, Sarah E Hudelson, Andrew D Redd, et al.Nature Communications|September 6, 2022
Genomic surveillance of SARS-CoV-2 Omicron variants on a university campusAna A Weil, Kyle G Luiten, Amanda M Casto, et al.Blood|June 28, 2013
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013Michele Baccarani, Michael W Deininger, Gianantonio Rosti, et al.Blood|July 4, 2018
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk diseaseSusan Branford, Paul Wang, David T Yeung, et al.The New England Journal of Medicine|December 12, 2019
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor FailureTimothy P Hughes, Michael J Mauro, Jorge E Cortes, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 18, 2016
Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 TrialSusan H Eshleman, Sarah E Hudelson, Andrew D Redd, et al.The Journal of Infectious Diseases|March 18, 2022
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084Susan H Eshleman, Jessica M Fogel, Estelle Piwowar-Manning, et al.Cell Reports|May 26, 2026
Host-microbial interactions at the nasal mucosa in young children and adults: A retrospective, cross-sectional studyJesús Reiné, Lisa A King, Youvika Singh, et al.Leukemia|March 5, 2020
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemiaA Hochhaus, M Baccarani, R T Silver, et al.Lancet (London, England)|April 4, 2022
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trialSinead Delany-Moretlwe, James P Hughes, Peter Bock, et al.Pageof 192